These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 28965855

  • 1. MicroRNA-148a-3p enhances cisplatin cytotoxicity in gastric cancer through mitochondrial fission induction and cyto-protective autophagy suppression.
    Li B, Wang W, Li Z, Chen Z, Zhi X, Xu J, Li Q, Wang L, Huang X, Wang L, Wei S, Sun G, Zhang X, He Z, Zhang L, Zhang D, Xu H, El-Rifai W, Xu Z.
    Cancer Lett; 2017 Dec 01; 410():212-227. PubMed ID: 28965855
    [Abstract] [Full Text] [Related]

  • 2. Poor expression of microRNA-135b results in the inhibition of cisplatin resistance and proliferation and induces the apoptosis of gastric cancer cells through MST1-mediated MAPK signaling pathway.
    Zhou J, Chen Q.
    FASEB J; 2019 Mar 01; 33(3):3420-3436. PubMed ID: 30576232
    [Abstract] [Full Text] [Related]

  • 3. circCUL2 regulates gastric cancer malignant transformation and cisplatin resistance by modulating autophagy activation via miR-142-3p/ROCK2.
    Peng L, Sang H, Wei S, Li Y, Jin D, Zhu X, Li X, Dang Y, Zhang G.
    Mol Cancer; 2020 Nov 05; 19(1):156. PubMed ID: 33153478
    [Abstract] [Full Text] [Related]

  • 4. miR-21 modulates cisplatin resistance of gastric cancer cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway.
    Gu Y, Fei Z, Zhu R.
    Anticancer Drugs; 2020 Apr 05; 31(4):385-393. PubMed ID: 31913198
    [Abstract] [Full Text] [Related]

  • 5. MiR-876-3p regulates cisplatin resistance and stem cell-like properties of gastric cancer cells by targeting TMED3.
    Peng C, Huang K, Liu G, Li Y, Yu C.
    J Gastroenterol Hepatol; 2019 Oct 05; 34(10):1711-1719. PubMed ID: 30843262
    [Abstract] [Full Text] [Related]

  • 6. Circular RNA MCTP2 inhibits cisplatin resistance in gastric cancer by miR-99a-5p-mediated induction of MTMR3 expression.
    Sun G, Li Z, He Z, Wang W, Wang S, Zhang X, Cao J, Xu P, Wang H, Huang X, Xia Y, Lv J, Xuan Z, Jiang T, Fang L, Yang J, Zhang D, Xu H, Xu Z.
    J Exp Clin Cancer Res; 2020 Nov 17; 39(1):246. PubMed ID: 33198772
    [Abstract] [Full Text] [Related]

  • 7. Long non-coding RNA NORAD/miR-224-3p/MTDH axis contributes to CDDP resistance of esophageal squamous cell carcinoma by promoting nuclear accumulation of β-catenin.
    Jia Y, Tian C, Wang H, Yu F, Lv W, Duan Y, Cheng Z, Wang X, Wang Y, Liu T, Wang J, Liu L.
    Mol Cancer; 2021 Dec 10; 20(1):162. PubMed ID: 34893064
    [Abstract] [Full Text] [Related]

  • 8. MiR-181a suppresses autophagy and sensitizes gastric cancer cells to cisplatin.
    Zhao J, Nie Y, Wang H, Lin Y.
    Gene; 2016 Feb 01; 576(2 Pt 2):828-33. PubMed ID: 26589846
    [Abstract] [Full Text] [Related]

  • 9. microRNAs: Key regulators of chemotherapy response and metastatic potential via complex control of target pathways in esophageal adenocarcinoma.
    Matuszcak C, Lindner K, Eichelmann AK, Hussey DJ, Haier J, Hummel R.
    Surg Oncol; 2018 Sep 01; 27(3):392-401. PubMed ID: 30217293
    [Abstract] [Full Text] [Related]

  • 10. MicroRNA-95-3p serves as a contributor to cisplatin resistance in human gastric cancer cells by targeting EMP1/PI3K/AKT signaling.
    Ni Q, Zhang Y, Tao R, Li X, Zhu J.
    Aging (Albany NY); 2021 Mar 10; 13(6):8665-8687. PubMed ID: 33714198
    [Abstract] [Full Text] [Related]

  • 11. Circular RNA AKT3 upregulates PIK3R1 to enhance cisplatin resistance in gastric cancer via miR-198 suppression.
    Huang X, Li Z, Zhang Q, Wang W, Li B, Wang L, Xu Z, Zeng A, Zhang X, Zhang X, He Z, Li Q, Sun G, Wang S, Li Q, Wang L, Zhang L, Xu H, Xu Z.
    Mol Cancer; 2019 Mar 30; 18(1):71. PubMed ID: 30927924
    [Abstract] [Full Text] [Related]

  • 12. LncRNA HOXA11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by Suppression of miR-214-3p Expression.
    Wang X, Li H, Shi J.
    Biomed Res Int; 2019 Mar 30; 2019():8645153. PubMed ID: 31275988
    [Abstract] [Full Text] [Related]

  • 13. HIF-1α-dependent miR-424 induction confers cisplatin resistance on bladder cancer cells through down-regulation of pro-apoptotic UNC5B and SIRT4.
    Yu M, Ozaki T, Sun D, Xing H, Wei B, An J, Yang J, Gao Y, Liu S, Kong C, Zhu Y.
    J Exp Clin Cancer Res; 2020 Jun 10; 39(1):108. PubMed ID: 32522234
    [Abstract] [Full Text] [Related]

  • 14. LncRNA ADAMTS9-AS2 inhibits gastric cancer (GC) development and sensitizes chemoresistant GC cells to cisplatin by regulating miR-223-3p/NLRP3 axis.
    Ren N, Jiang T, Wang C, Xie S, Xing Y, Piao D, Zhang T, Zhu Y.
    Aging (Albany NY); 2020 Jun 09; 12(11):11025-11041. PubMed ID: 32516127
    [Abstract] [Full Text] [Related]

  • 15. LncRNA MALAT1 potentiates autophagy‑associated cisplatin resistance by regulating the microRNA‑30b/autophagy‑related gene 5 axis in gastric cancer.
    Xi Z, Si J, Nan J.
    Int J Oncol; 2019 Jan 09; 54(1):239-248. PubMed ID: 30365113
    [Abstract] [Full Text] [Related]

  • 16. Mitochondrial fission causes cisplatin resistance under hypoxic conditions via ROS in ovarian cancer cells.
    Han Y, Kim B, Cho U, Park IS, Kim SI, Dhanasekaran DN, Tsang BK, Song YS.
    Oncogene; 2019 Nov 09; 38(45):7089-7105. PubMed ID: 31409904
    [Abstract] [Full Text] [Related]

  • 17. Induction of autophagy counteracts the anticancer effect of cisplatin in human esophageal cancer cells with acquired drug resistance.
    Yu L, Gu C, Zhong D, Shi L, Kong Y, Zhou Z, Liu S.
    Cancer Lett; 2014 Dec 01; 355(1):34-45. PubMed ID: 25236911
    [Abstract] [Full Text] [Related]

  • 18. p53 is required for cisplatin-induced processing of the mitochondrial fusion protein L-Opa1 that is mediated by the mitochondrial metallopeptidase Oma1 in gynecologic cancers.
    Kong B, Wang Q, Fung E, Xue K, Tsang BK.
    J Biol Chem; 2014 Sep 26; 289(39):27134-27145. PubMed ID: 25112877
    [Abstract] [Full Text] [Related]

  • 19. MiR-26a enhances the sensitivity of gastric cancer cells to cisplatin by targeting NRAS and E2F2.
    Wen L, Cheng F, Zhou Y, Yin C.
    Saudi J Gastroenterol; 2015 Sep 26; 21(5):313-9. PubMed ID: 26458859
    [Abstract] [Full Text] [Related]

  • 20. CircRNACCDC66 regulates cisplatin resistance in gastric cancer via the miR-618/BCL2 axis.
    Zhang Q, Miao Y, Fu Q, Hu H, Chen H, Zeng A, Jin Y, Jiang Y, Qian L, Wu L, Xu L, Wang G, Qiu L, Huang X, Xia Y.
    Biochem Biophys Res Commun; 2020 Jun 04; 526(3):713-720. PubMed ID: 32253030
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.